Discover open access scientific publications

Search, annotate, share and cite publications

Response-Adapted Intensification With Cyclophosphamide, Bortezomib, and Dexamethasone Versus No Intensification in Patients With Newly Diagnosed Multiple Myeloma (Myeloma XI): A Multicentre, Open-Label, Randomised, Phase 3 Trial

The Lancet Haematology

Hematology

2019

English

The Long-Sought-After Plant Heterochromatin Protein 1

English

Future Recovery of Baleen Whales Is Imperiled by Climate Change

Global Change Biology

Planetary Change

Environmental Chemistry

Global

Ecology

Environmental Science

2019

English

Nivolumab in Chemotherapy-Resistant Cervical Cancer: Report of a Vulvitis as a Novel Immune-Related Adverse Event and Molecular Analysis of a Persistent Complete Response

Journal for ImmunoTherapy of Cancer

English

Bowel Biofilms: Tipping Points Between a Healthy and Compromised Gut?

Trends in Microbiology

English

The Genome of Cucurbita Argyrosperma (Silver-Seed Gourd) Reveals Faster Rates of Protein-Coding Gene and Long Noncoding RNA Turnover and Neofunctionalization Within Cucurbita

English

Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Uveitis Affecting the Posterior Segment: 12-Month Results

Ophthalmology

2019

English

Lentiviral Haemopoietic Stem/Progenitor Cell Gene Therapy for Treatment of Wiskott-Aldrich Syndrome: Interim Results of a Non-Randomised, Open-Label, Phase 1/2 Clinical Study

The Lancet Haematology

Hematology

2019

English

Regulation of Resource Partitioning Coordinates Nitrogen and Rhizobia Responses and Autoregulation of Nodulation in the Legume Medicago Truncatula

English

Moving Cancer Immunotherapy Forward Through the Journal for ImmunoTherapy of Cancer (JITC)

Journal for ImmunoTherapy of Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Response-Adapted Intensification With Cyclophosphamide, Bortezomib, and Dexamethasone Versus No Intensification in Patients With Newly Diagnosed Multiple Myeloma (Myeloma XI): A Multicentre, Open-Label, Randomised, Phase 3 Trial

The Long-Sought-After Plant Heterochromatin Protein 1

Future Recovery of Baleen Whales Is Imperiled by Climate Change

Nivolumab in Chemotherapy-Resistant Cervical Cancer: Report of a Vulvitis as a Novel Immune-Related Adverse Event and Molecular Analysis of a Persistent Complete Response

Bowel Biofilms: Tipping Points Between a Healthy and Compromised Gut?

The Genome of Cucurbita Argyrosperma (Silver-Seed Gourd) Reveals Faster Rates of Protein-Coding Gene and Long Noncoding RNA Turnover and Neofunctionalization Within Cucurbita

Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Uveitis Affecting the Posterior Segment: 12-Month Results

Lentiviral Haemopoietic Stem/Progenitor Cell Gene Therapy for Treatment of Wiskott-Aldrich Syndrome: Interim Results of a Non-Randomised, Open-Label, Phase 1/2 Clinical Study

Regulation of Resource Partitioning Coordinates Nitrogen and Rhizobia Responses and Autoregulation of Nodulation in the Legume Medicago Truncatula

Moving Cancer Immunotherapy Forward Through the Journal for ImmunoTherapy of Cancer (JITC)